Operation Warp Speed (OWS), the government program to accelerate
vaccine development, is offering help to increase production of the
vaccine developed by Pfizer and German partner BioNTech, the FT
reported. (https://on.ft.com/3gDNB1I)
The Pfizer vaccine is awaiting emergency use authorization in the
United States after a panel of outside advisers to the U.S. Food and
Drug Administration on Thursday voted overwhelmingly to endorse
emergency use.
The United States has already ordered 100 million doses of the
two-dose vaccine.
[to top of second column] |
OWS is trying to help Pfizer obtain more raw material under the Defense
Production Act, so the company can produce the extra doses by June 2021, FT's
sources said.
Pfizer and the U.S. Department of Health and Human Services did not immediately
respond to a Reuters request for comment.
(Reporting by Manas Mishra in Bengaluru; Editing by Vinay Dwivedi)
[© 2020 Thomson Reuters. All rights
reserved.] Copyright 2020 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content. |